These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3423432)

  • 1. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.
    Cunha-Vaz JG; Gray JR; Zeimer RC; Mota MC; Ishimoto BM; Leite E
    Diabetes; 1985 Jan; 34(1):53-9. PubMed ID: 3964755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous fluorophotometry in juvenile diabetics after oral fluorescein.
    Nuzzi G; Vanelli M; Venturini I; Bonacini M; Boselli E
    Arch Ophthalmol; 1986 Nov; 104(11):1630-1. PubMed ID: 3778277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy.
    Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
    Diabetes; 1986 May; 35(5):574-8. PubMed ID: 3514333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous fluorophotometry in insulin-dependent diabetes mellitus. Correlation with microalbuminuria and diastolic blood pressure.
    Jackson WE; Chase HP; Garg SK; Bartlett DA; Hoops S; Harris S; Marshall G; Ishimoto BM
    Arch Ophthalmol; 1990 Dec; 108(12):1733-5. PubMed ID: 2256845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
    Kernell A; Ludvigsson J; Finnström K
    Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of the results of vitreous fluorophotometry and fluorescein angiography in nonproliferative diabetic retinopathy.
    Stur M; Reitner A; Irsigler K
    Retina; 1988; 8(1):50-4. PubMed ID: 3406544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new method in the analysis of vitreous fluorophotometry. Results in early diabetic retinopathy].
    Roy MS; Bungay P; Collier B; Bonner R
    Ophtalmologie; 1989; 3(3):214-6. PubMed ID: 2641114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
    Yoshida A; Kojima M; Ogasawara H; Ishiko S
    Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the blood-retinal barrier and vitreous in sickle cell retinopathy.
    Paylor RR; Carney MD; Ogura Y; Cunha-Vaz JG; Jampol LM; Goldberg MF
    Int Ophthalmol; 1986 May; 9(2-3):103-8. PubMed ID: 3721713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative retinopathy.
    Lobo CL; Bernardes RC; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2001 Oct; 119(10):1469-74. PubMed ID: 11594946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.